Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$697,937
in 4 filings, $698K under 10b5-1 plans

Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-09-05 POPS RICHARD F Director and CEO, Alkermes plc Exercise or conversion · Employee Stock Option (Right to Buy) −100,000 400,000
2019-07-01 MITCHELL PAUL J Director Exercise or conversion +7,000 $8.98 $63K 7,000
2019-07-01 MITCHELL PAUL J Director Exercise or conversion · Non Qualified Stock Option (Right to Buy) −7,000 0
2019-06-07 Hopkinson Craig C. SVP, Med Dev/Med Affairs, CMO Exercise or conversion +1,250 7,245
2019-06-07 Hopkinson Craig C. SVP, Med Dev/Med Affairs, CMO Shares withheld for taxes −368 $22.83 $8K 6,877
2019-06-07 Hopkinson Craig C. SVP, Med Dev/Med Affairs, CMO Exercise or conversion · Restricted Stock Unit Award −1,250 2,500
2019-05-23 POPS RICHARD F Director and CEO, Alkermes plc Exercise or conversion +50,000 $8.55 $428K 766,433
2019-05-23 POPS RICHARD F Director and CEO, Alkermes plc Sale −50,000 $24.22 $1.2M 716,433
2019-05-23 POPS RICHARD F Director and CEO, Alkermes plc Exercise or conversion · Employee Stock Option (Right to Buy) −50,000 0
2019-05-22 Wysenski Nancy Director Grant or award · Non Qualified Stock Option (Right to Buy) +22,400 22,400
2019-05-22 snyderman nancy lynn MD Director Grant or award · Non Qualified Stock Option (Right to Buy) +22,400 22,400
2019-05-22 MITCHELL PAUL J Director Grant or award · Non Qualified Stock Option (Right to Buy) +22,400 22,400
2019-05-22 DIXON WENDY L Director Grant or award · Non Qualified Stock Option (Right to Buy) +22,400 22,400
2019-05-22 Cooke Shane Director Grant or award · Non Qualified Stock Option (Right to Buy) +22,400 22,400
2019-05-22 BREYER ROBERT A Director Grant or award · Non Qualified Stock Option (Right to Buy) +22,400 22,400
2019-05-22 BLOOM FLOYD E Director Grant or award · Non Qualified Stock Option (Right to Buy) +22,400 22,400
2019-05-22 ANSTICE DAVID W Director Grant or award · Non Qualified Stock Option (Right to Buy) +22,400 22,400
2019-05-22 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Exercise or conversion +8,304 $8.55 $71K 193,426
2019-05-22 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Exercise or conversion +11,696 $8.55 $100K 205,122
2019-05-22 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Sale −20,000 $24.93 $499K 185,122

Page 80 of 90 · 1,796 trades